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904Objective: Liver fibrosis has emerged as an important long-term complication of the Fontan operation. We
aimed to describe liver histology at autopsy in patients who had undergone the Fontan operation and to deter-
mine whether patient variables are associated with the degree of fibrosis.
Methods: A review was performed of all patients with a history of the Fontan operation who died and un-
derwent autopsy at our institution from 1980 to 2009. Autopsy liver slides were evaluated independently by 2
pathologists.
Results: Twenty-two patients were studied. The median interval between Fontan and death was 20 days (range,
1 day–17.5 years). Portal fibrosis was observed in 20 (91%) patients and sinusoidal fibrosis was observed in 17
(77%) patients. Using simple linear regression, time from the Fontan operation was significantly associated with
the degree of portal fibrosis on Ishak (P¼ .03) and modified Scheuer fibrosis (P¼ .02) scales. Significant portal
fibrosis was observed in 8 (57%) of the 14 patients who died 30 days or less after the Fontan operation. In these
14 patients, severity of portal fibrosis was associated with length of hospitalization after pre-Fontan cardiac op-
erations (P ¼ .03) and pre-Fontan mean right atrial pressure (P ¼ .04).
Conclusions: At autopsy, hepatic fibrosis was commonly observed in patients who had undergone the Fontan
operation. Portal fibrosis has been previously unrecognized in this population. Significant portal fibrosis oc-
curred in most who died soon after the Fontan procedure and was associated with pre-Fontan morbidity. Hepatic
disease in the single-ventricle population is multifactorial and may begin before the Fontan operation. (J Thorac
Cardiovasc Surg 2012;143:904-9)The Fontan operation was first described in 1971 and has
become a widely used palliation for patients with single-
ventricle congenital heart disease.1 Over the past 40 years,
the Fontan operation has undergone several modifications,
but its basic principle remains constant: blood flows pas-
sively through the pulmonary vascular bed as a total cavo-
pulmonary connection routes systemic venous return
directly to the pulmonary arterial circulation.
Survival after the Fontan procedure has improved over
the past 4 decades; however, complications of the abnormal
circulation have developed, including liver fibrosis and cir-
rhosis.2-4 Hepatic fibrosis was first described in this
population in 1981 and is now recognized by cardiologists
and hepatologists as an important long-term complication
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The Journal of Thoracic and Cardiovascular Surgexpectancy.5 Liver cirrhosis is associated with significant
morbidity including hepatocellular carcinoma and may pre-
clude cardiac transplantation, a therapeutic option for some
patients.6
Few reports exist that describe pathologic changes in liver
histology in patients who have undergone the Fontan opera-
tion. Indeed, risk factors for the development of hepatic fi-
brosis have not been clearly identified.6-8 Moreover, the
liver fibrosis that has been previously reported has been
centrilobular, affecting the area around the central vein
and extending outward along the sinusoids (sinusoidal
fibrosis). Portal-based fibrosis, as typically seen in inflam-
matory hepatopathies, has not been observed in patients
who have had the Fontan operation.6-8 We aimed to charac-
terize hepatic histology in children and adolescents who
died after the Fontan operation and to determinewhether de-
mographic, anatomic, surgical, temporal, and clinical vari-
ables were associated with the degree of observed hepatic
fibrosis in these patients.METHODS
Patients
The study protocol was approved by the Institutional Review Board at
the Children’s Hospital of Philadelphia. We retrospectively identified all
patients who underwent the Fontan operation, died, and subsequently un-
derwent autopsy at the Children’s Hospital of Philadelphia between Janu-
ary 1980 and December 2009. Patients were included if the autopsyery c April 2012
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available. Patients with another known cause of liver disease such as viral
hepatitis were excluded.
Themedical history of each patient was reviewed, and demographic, an-
atomic, surgical, temporal, and clinical variables were extracted. Because
all included patients underwent autopsy, the cardiac specimen of each pa-
tient was reviewed to confirm intracardiac anatomy and Fontan type.
Histologic Grading
Paraffin-embedded, 10% neutral buffered formalin-fixed, 4-um–thick
sections were obtained from each autopsy block that included sections of
liver tissue. Each slide was deparaffinized with xylene and stained with he-
matoxylin and eosin, reticulin, Gomori trichrome, or reticulin. Each slide
was then reviewed independently by 2 pathologists (P.R., L.S.) who were
blinded to all patient variables. Histologic characteristics were graded
semiquantitatively as summarized in Appendix 1. Portal fibrosis was
graded using 2 staging systems that have been used extensively in patients
with chronic inflammatory hepatopathies, the Ishak fibrosis stage and
the modified Scheuer fibrosis stage.9-11 Hepatic sinusoidal fibrosis was
graded using an adaptation of a scale previously published8 and portal in-
flammation was graded. If the 2 pathologists scored a feature of the spec-
imen differently, then they conferred to arrive at a final score.
Statistical Analysis
Summary statistics are reported as median with range or number of pa-
tients with percentage. Simple linear regression was used to determine
whether patient variables were significantly associated with histologic
grading results. Inasmuch as histologic grades are ordinal, the more sophis-
ticated cumulative logit model was also conducted to confirm the results of
simple linear regression.
RESULTS
Patient Characteristics
Twenty-two patients met inclusion criteria and their base-
line characteristics are summarized in Table 1. Sixteen
(72%) patients had hypoplastic left heart syndrome, 3
(14%) had tricuspid atresia, and 3 (14%) had otherTABLE 1. Baseline characteristics of 22 patients with Fontan
circulation
Result*
Demographic
Sex, male 14 (64%)
Age at Fontan operation (y) 1.62 (0.86-5.75)
Age at death (y) 1.97 (0.93-23.25)
Fontan-to-death interval 20 ds (1 d–17.5 y)
Year Fontan operation performed 1989 (1985-2004)
Anatomic
Hypoplastic left heart syndrome 16 (72%)
Tricuspid atresia 3 (14%)
Other 3 (14%)
Surgical
Type of Fontan operation
Lateral tunnel 15 (68%)
Extracardiac 2 (9%)
Atriopulmonary 2 (9%)
Other 3 (14%)
Fenestrated Fontan 6 (27%)
*Expressed as median with range or as number.
The Journal of Thoracic and Casingle-ventricle malformations. Fifteen (68%) patients un-
derwent a lateral tunnel Fontan, 2 (9%) an extracardiac
Fontan, 2 (9%) an atriopulmonary Fontan, 2 (9%) had an
intra-atrial tube graft placed from the inferior vena cava
to the right pulmonary artery, and 1 a right atrium–right
ventricle Fontan connection. Six (27%) of the Fontan baf-
fles were fenestrated. The median age at the time of Fontan
procedure was 1.62 years (range, 0.86-5.75 years) and the
median interval between Fontan operation and death was
20 days (range, 1 day–17.5 years). The median age at death
was 1.97 years (range, 0.93-23.25 years). The Fontan oper-
ations were performed from 1985 to 2004 and the median
year of operation was 1989.
The most common cause of death was cardiac failure
(Table 2). Three patients underwent cardiac transplantation
for failing Fontan physiology. One patient (No. 19) died
during the transplantation, and postmortem cultures grew
Staphylococcus pneumoniae and Staphylococcus aureus,
another patient (no. 22) died 2 days after transplantation
of postoperative bleeding, and another (no. 20) died 4
months after heart transplant with ongoing graft rejection,
cytomegalovirus gastritis, and acute cerebral hemorrhage.
Hepatitis C status was only documented in 3 of the patients
(nos. 19, 21, and 22), all of whom were negative. The 3 lon-
gest surviving patients (nos. 20-22) had a history of protein-
losing enteropathy.
Histologic Findings and Analysis
Histologic grading of portal fibrosis and sinusoidal fibro-
sis for each patient is listed in Table 2. Twenty (90%) pa-
tients had at least some degree of portal fibrosis by Ishak
or modified Scheuer scales. Significant portal fibrosis was
common; 9 (41%) patients had Ishak stage 3 or greater
and 9 (41%) patients had modified Scheuer stage 2 or
greater. Figure 1, A, shows Ishak stage 4 and modified Sche-
uer stage 3 fibrosis in a 20.1-year-old patient with tricuspid
atresia who died 16.5 years after undergoing atriopulmo-
nary Fontan. Portal-based cirrhosis (Ishak stage 6 or modi-
fied Scheuer stage 4) was uncommon and found in only 1
patient, shown in Figure 1, B,who had hypoplastic left heart
syndrome and died 4.0 years after lateral tunnel Fontan.
Of note, portal fibrosis was common in those who died
within 1 month of the Fontan operation because 12 of 14
(86%) patients showed at least some degree of fibrosis by
Ishak or modified Scheuer scales. Figure 1, C, shows stage
4 Ishak fibrosis in a 2-year-old child with hypoplastic left
heart syndrome who died 1 day after a lateral tunnel Fontan
procedure.
At least some degree of sinusoidal fibrosis was found in
17 (77%) patients (Table 2). Of the 5 patients who had no
sinusoidal fibrosis, 4 died 20 days or less after the Fontan
operation. Ten of the 14 patients who died within 1 month
of Fontan had at least some degree of sinusoidal fibrosis,
but only 2 had sinusoidal fibrosis greater than stage 1.rdiovascular Surgery c Volume 143, Number 4 905
TABLE 2. Histologic liver findings at autopsy in 22 Fontan patients
Pt
no.
Age at
death (y)
Death
(y)
Fontan to
death interval Anatomy
Fontan
type
Ishak
fibrosis
stage (0-6)
Scheuer
fibrosis
stage (0-4)
Sinusoidal
fibrosis
score (0-4) Cause of death
1 1.28 1987 1 d HLHS LT 0 0 1 Cardiac failure
2 2.04 1988 1 d HLHS LT 4 2 1 Bleeding
3 0.97 1986 3 d HLHS IAT 3 2 1 Bleeding
4 2.02 2001 3 d HLHS EC 2 1 1 Cardiac failure
5 1.89 1994 4 d HLHS LT 2 1 0 Hypoxemic brain injury
6 2.39 1987 4 d HLHS LT 1 1 1 Cardiac failure
7 1.32 1987 4 d HLHS AP 1 1 1 Cardiac failure
8 1.33 2004 6 d HLHS EC 3 2 2 Bleeding
9 1.43 1987 6 d HLHS LT 0 0 0 Cardiac failure
10 1.58 1990 10 d TA LT 2 1 0 Cardiac failure
11 1.92 1990 20 d HLHS LT 3 2 1 Empyema
12 1.45 1994 20 d HLHS LT 1 0 0 Cardiac failure
13 0.93 1988 24 d HLHS LT 1 1 4 Pneumothorax
14 2.38 1990 30 d DORV, MA LT 2 1 1 Sepsis
15 1.41 1988 81 d HLHS LT 1 1 1 Cardiac arrest
16 2.17 1988 183 d TA RA-RV 4 2 2 Cardiac arrest
17 2.38 1994 223 d HLHS LT 3 2 2 Cardiac failure
18 4.13 2003 323 d HLHS LT 2 1 2 Cardiac arrest
19 5.57 1999 4.0 y HLHS LT 6 4 1 Cardiac failure, sepsis
20 15.3 2000 13.8 y DILV IAT 2 1 0 Cardiac failure, CMV gastritis,
brain hemorrhage
21 20.1 2005 16.5 y TA AP 4 3 2 Sepsis
22 23.2 2002 17.5 y Single RV LT 3 2 1 Cardiac failure, bleeding
HLHS, Hypoplastic left heart syndrome; LT, lateral tunnel; IAT, intra-atrial tube graft; EC, extracardiac; AP, atriopulmonary; TA, tricuspid atresia; DORV, double-outlet right
ventricle; MA, mitral atresia; RA-RV, right atrial–right ventricular; DILV, double-inlet left ventricle, RV, right ventricle.
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diac cirrhosis); this patient died 24 days after lateral tunnel
Fontan owing to multiple pneumothoraces. Figure 1, D,
shows grade 2 sinusoidal fibrosis in a 4-year-old boy with
hypoplastic left heart syndrome who died of cardiac arrest
11 months after a lateral tunnel Fontan operation.
Portal inflammation was uncommon because 14 (64%)
patients had no inflammation, 7 (32%) had mild inflamma-
tion, 1 (5%) had moderate inflammation, and no patients
had severe inflammation. Of the 7 patients with mild inflam-
mation, 2 died of sepsis and 1 died of cardiac arrest in the
setting of gastroenteritis. The patient with moderate inflam-
mation died of an empyema.
For regression analysis, time from Fontan was trans-
formed using the natural log scale because the variable is
not normally distributed. After this transformation, time
from Fontan was significantly associated with Ishak
(P ¼ .03) and modified Scheuer (P ¼ .02) fibrosis stages
(Figure 2, A and B). Time from Fontan was not associated
with the severity of sinusoidal fibrosis. Other patient vari-
ables including age at Fontan, cardiac anatomy, Fontan
type, and presence of fenestration were not associated
with Ishak fibrosis stage, modified Scheuer fibrosis stage,
or sinusoidal fibrosis stage. Also, the degree of portal fibro-
sis, by either Ishak or modified Scheuer fibrosis stage, was906 The Journal of Thoracic and Cardiovascular Surgnot significantly associated with the degree of portal inflam-
mation. Analysis with the cumulative logit model con-
firmed the simple linear regression results.
Further analysis of the patients who died less than
a month after the Fontan operation (n¼ 14) was performed.
Table 3 summarizes relevant pre-Fontan characteristics of
these patients. By simple linear regression, length of hospi-
talization after pre-Fontan cardiac operations (P ¼ .03) and
mean right atrial pressure at pre-Fontan catheterization
(P ¼ .04) were significantly associated with Ishak fibrosis
stage (Figure 3, A and B) in a univariate model. For every
50 days of hospitalization, the Ishak fibrosis stage increased
by 1 unit; for every 3-mm Hg increase in right atrial pres-
sure, the Ishak fibrosis stage increased by 1 unit. Systemic
ventricular end-diastolic pressure at pre-Fontan catheteriza-
tion (P ¼ .3) and pre-Fontan hemoglobin (P ¼ .8) were not
significantly associated with degrees of Ishak fibrosis. The
degree of sinusoidal fibrosis was not significantly associ-
ated with any of the pre-Fontan variables by simple linear
regression. Cumulative logit model confirmed linear regres-
sion results.
DISCUSSION
Hepatic fibrosis has emerged as an important sequela of
the Fontan operation with potentially serious long-termery c April 2012
FIGURE 1. A, Trichrome stain at 23magnification from patient 21 showing significant portal fibrosis in a long-term survivor after the Fontan procedure.
B, Ttrichrome stain at 43magnification from patient 19 showing portal-based cirrhosis 4 years after the Fontan procedure. C, Trichrome stain at 43 mag-
nification from patient 2 showing significant portal fibrosis only 1 day after the Fontan operation. D, Trichrome stain at 103 from patient 18 showing si-
nusoidal fibrosis extending from a central vein 11 months after the Fontan procedure.
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tion has not been emphasized.3,4 Few descriptions of
hepatic histology after Fontan exist and factors associated
with the development of fibrosis are poorly defined.6-8
Our report is the largest histologic examination of the
liver in patients who have undergone the Fontan operation
to date and is the first to describe significant portal
fibrosis after the operation. It is also the first to describe
fibrosis that likely developed before the Fontan procedure.
Previous reports assessing hepatic histology after the
Fontan operation have described centrilobular, sinusoidal fi-
brosis6-8; portal-based fibrosis has not been reported. Two
of these studies examined the relationship between patient
characteristics and histologic findings, suggesting that
time from Fontan and central venous pressure elevation
are risk factors for centrilobular, sinusoidal fibrosis.6,7
In our cohort, most patients showed evidence of both por-
tal and sinusoidal fibrosis. In addition, time from the Fontan
operation was associated with portal fibrosis. The etiology
of the portal fibrosis in this population is unknown. Portal
fibrosis is commonly reported in inflammatory hepatopa-
thies, but it may also be a reflection of elevated central ve-
nous pressure and diminished oxygen delivery that
characterize the Fontan circulation. However, unique fac-
tors such as medication toxicity, genetic abnormalities, or
undiagnosed chronic infection such as hepatitis C mayThe Journal of Thoracic and Caalso be responsible for portal-based disease. Data from
the United States and Europe suggest that 8% to 14% of pa-
tients who underwent surgery for congenital heart disease
before 1992 are seropositive for hepatitis C antibodies.12,13
The median year of surgery in our cohort was 1989, placing
many of the patients at risk for hepatitis C infection.
However, 3 of the longest-surviving patients in our cohort
had documentation of negative hepatitis C status. Also, un-
diagnosed hepatitis C is unlikely to account for the portal
fibrosis observed in patients that died soon after the Fontan
operation because of their young age. Portal inflammation
was uncommon in our cohort and was not associated with
the degree of portal fibrosis.
Sinusoidal liver fibrosis after the Fontan procedure is
thought to occur because hepatocytes that surround the cen-
tral vein experience direct transmission of central venous
pressure and are most vulnerable to diminished oxygen de-
livery.6 In our cohort, nearly all of the patients without sinu-
soidal fibrosis died less than 30 days after the Fontan
operation and, thus, had limited exposure to central venous
pressure elevation. The degree of sinusoidal fibrosis was not
associated with time from Fontan, possibly because there
were only 8 patients who died more than 30 days after
surgery.
Significant hepatic fibrosis soon after Fontan has not been
previously described. At autopsy, 12 of 14 patients who diedrdiovascular Surgery c Volume 143, Number 4 907
FIGURE 2. A, Simple linear regression analysis of Ishak fibrosis stage
and the natural log of time from Fontan interval in 22 patients. B, Simple
linear regression analysis of modified Scheuer fibrosis stage and the natural
log of time from Fontan interval in 22 patients.
FIGURE 3. A, Simple linear regression analysis of length of hospitaliza-
tion after pre-Fontan cardiac operations and Ishak fibrosis stage in 14 pa-
tients who died 30 days or less after the Fontan operation. B, Simple
linear regression analysis of pre-Fontan mean right atrial pressure and
Ishak fibrosis stage in 14 patients who died 30 days or less after the Fontan
operation.
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Dless than 30 days after the Fontan operation showed portal
fibrosis. In many of these patients, the fibrosis was signifi-
cant. Liver fibrosis is a subacute process and generally takes
weeks to months to occur. Thus, it is likely that the fibrosis
seen in this subset of patients is a result of pre-Fontan in-
sults. Markers of pre-Fontan morbidity, including length
of hospitalization after pre-Fontan cardiac operations and
pre-Fontan mean right atrial pressure, were significantly as-
sociated with the degree of portal fibrosis among these pa-
tients. Prolonged hospitalizations before the Fontan
operation with repeated episodes of decreased oxygen de-
livery might lead to hepatic fibrosis. For example, 1 patient
who died 1 day after the Fontan operation had liverTABLE 3. Pre-Fontan characteristics in the 14 patients who died
within 30 days after Fontan operation
Patient characteristic (n ¼ 14) Result*
Hypoplastic left heart syndrome 12 (86%)
No. of Pre-Fontan cardiac operations 1.5 (1-3)
Cumulative length of hospitalization after
pre-Fontan cardiac operations (d)
37.5 (10-114)
Pre-Fontan mean right atrial pressure (mm Hg) 6 (3-10)
Pre-Fontan systemic ventricular end-diastolic
pressure (mm Hg)
8 (3-12)
*Median (range) or number (%).
908 The Journal of Thoracic and Cardiovascular Surghistology that showed stage 4 Ishak fibrosis. This patient
had a protracted hospital course after the Norwood proce-
dure including intubation for 3 months. Mean right atrial
pressure before the Fontan operation was also associated
with the degree of portal fibrosis in patients who died
soon after surgery. Elevated right atrial pressure before
the Fontan procedure is likely a surrogate marker of ventric-
ular diastolic dysfunction. Patients with dysfunctional
systemic ventricles and higher ventricular end-diastolic
pressures before the Fontan procedure may have high he-
patic venous pressures and diminished cardiac output, plac-
ing them at risk for liver fibrosis.
The etiology of hepatic fibrosis after the Fontan operation
is likely multifactorial. We have shown that pre-Fontan
morbidity is associated with hepatic portal fibrosis at the
time of Fontan and have demonstrated that time from sur-
gery is a risk factor for the development of further portal-
based disease. The presence of fibrosis at Fontan may place
patients at risk for accelerated progression of disease after
surgery. Prospective investigation of liver histology before
and after Fontan completion is needed.ery c April 2012
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There are several important limitations to our study. The
majority of patients in our cohort had hypoplastic left heart
syndrome and a history of lateral tunnel, nonfenestrated
Fontan. As a result, statistical analysis of possible anatomic
and surgical risk factors for hepatic fibrosis was limited.
Also, although most patients died of cardiac failure, other
causes of death were represented that may have affected he-
patic histology. However, fibrosis is a subacute process that
is unlikely to develop as a result of acute insults such as in-
fection or cardiopulmonary collapse. We excluded patients
with a known cause of liver disease, but extensive serum
testing for viral hepatitis was not routinely performed in
these patients. Finally, as this was an autopsy examination
of hepatic histology, this may be a biased population of Fon-
tan patients and may not be applicable to the general popu-
lation of children who have had the Fontan operation.C
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DCONCLUSIONS
At autopsy, portal fibrosis was commonly observed in pa-
tients who have undergone the Fontan operation and was as-
sociated with time from the operation. Portal-based fibrosis
has been previously unrecognized in this population and
warrants further investigation into its etiology. Importantly,
significant portal fibrosis occurred in the majority of pa-
tients who died soon after the Fontan procedure and was as-
sociated with pre-Fontan morbidity. These findings suggest
that the hepatic disease in the single-ventricle population is
multifactorial and may in fact begin before the Fontan oper-
ation. As the survival of patients with single-ventricle heartAPPENDIX 1. Histopathologic grading system used to evaluate hepatic sp
Feature Score
Ishak portal fibrosis stage 0 No fibrosis
1 Fibrous expansion
2 Fibrous expansion
3 Fibrous expansion
4 Fibrous expansion o
5 Marked bridging (p
6 Cirrhosis, probable
Modified Scheuer portal fibrosis stage 0 No fibrosis
1 Enlarged, fibrotic p
2 Periportal or portal
3 Fibrosis with distor
4 Cirrhosis, probable
Sinusoidal fibrosis 0 No fibrosis
1 Fibrosis present in
2 Fibrosis present in
3 Fibrosis present in
4 Cardiac cirrhosis (e
Portal inflammation 0 No inflammation
1 Mild inflammation
2 Moderate inflamma
3 Severe inflammatio
The Journal of Thoracic and Cadisease continues to improve, the number of adults with
Fontan circulation promises to increase. Continued study
is needed to understand the timing of liver injury and risk
factors for its development and progression.
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Description
of less than half of portal areas with or without short fibrous septa
of most (more than half) portal areas with or without short fibrous septa
of most portal areas with occasional portal–portal bridging
f most portal areas with marked bridging (portal–portal and portal–central)
ortal–portal and/or portal–central) with occasional nodules
or definite
ortal tracts
–portal septa, but intact architecture
ted architecture but no obvious cirrhosis
or definite
less than one thirdof sinusoids
one third to two thirds of sinusoids
more than two thirds of sinusoids
xtensive central vein–central vein bridging)
in some or all portal areas
tion in some or all portal areas
n in all portal areas
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